NO923049L - Substituerte dibenz(b,f)(1,4)oksazepin-11(10h)-oner, fremgangsmaate til fremstilling derav og preparater inneholdende slike - Google Patents

Substituerte dibenz(b,f)(1,4)oksazepin-11(10h)-oner, fremgangsmaate til fremstilling derav og preparater inneholdende slike

Info

Publication number
NO923049L
NO923049L NO92923049A NO923049A NO923049L NO 923049 L NO923049 L NO 923049L NO 92923049 A NO92923049 A NO 92923049A NO 923049 A NO923049 A NO 923049A NO 923049 L NO923049 L NO 923049L
Authority
NO
Norway
Prior art keywords
oksazepin
ones
procedures
preparing
preparations containing
Prior art date
Application number
NO92923049A
Other languages
English (en)
Other versions
NO923049D0 (no
NO301586B1 (no
Inventor
Ivo Monkovic
Lotte Wang
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO923049D0 publication Critical patent/NO923049D0/no
Publication of NO923049L publication Critical patent/NO923049L/no
Publication of NO301586B1 publication Critical patent/NO301586B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/04—Seven-membered rings having the hetero atoms in positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO923049A 1991-08-26 1992-08-03 Dibenz£b,f|£1,4|oksazepin-11(10H)oner, fremgangsmåte til fremstilling derav og farmasöytisk preparat inneholdende dem NO301586B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/749,741 US5173486A (en) 1991-08-26 1991-08-26 Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents

Publications (3)

Publication Number Publication Date
NO923049D0 NO923049D0 (no) 1992-08-03
NO923049L true NO923049L (no) 1993-03-01
NO301586B1 NO301586B1 (no) 1997-11-17

Family

ID=25014983

Family Applications (2)

Application Number Title Priority Date Filing Date
NO923049A NO301586B1 (no) 1991-08-26 1992-08-03 Dibenz£b,f|£1,4|oksazepin-11(10H)oner, fremgangsmåte til fremstilling derav og farmasöytisk preparat inneholdende dem
NO972247A NO309603B1 (no) 1991-08-26 1997-05-16 Fremgangsmåte til fremstilling av substituerte dibenz[b,f][1,4]-oksazepin-11(10H)oner

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO972247A NO309603B1 (no) 1991-08-26 1997-05-16 Fremgangsmåte til fremstilling av substituerte dibenz[b,f][1,4]-oksazepin-11(10H)oner

Country Status (22)

Country Link
US (1) US5173486A (no)
EP (1) EP0529386B1 (no)
JP (1) JP3136427B2 (no)
KR (1) KR100204119B1 (no)
CN (1) CN1038749C (no)
AT (1) ATE149158T1 (no)
AU (1) AU642602B2 (no)
CA (1) CA2075861C (no)
DE (1) DE69217594T2 (no)
DK (1) DK0529386T3 (no)
ES (1) ES2097841T3 (no)
FI (1) FI112656B (no)
GR (1) GR3022698T3 (no)
HK (1) HK1005029A1 (no)
HU (1) HU214584B (no)
IL (1) IL102542A (no)
MX (1) MX9204791A (no)
NO (2) NO301586B1 (no)
PL (1) PL168707B1 (no)
RU (1) RU2086545C1 (no)
TW (1) TW213905B (no)
ZA (1) ZA925287B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8914061D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
US5767113A (en) * 1995-05-10 1998-06-16 The Salk Institute For Biological Studies Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance
US6407125B1 (en) 1995-12-29 2002-06-18 Novactyl, Inc. Pharmacological agent and method of treatment
US6579891B1 (en) 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
US6743771B2 (en) 1995-12-29 2004-06-01 Novactyl, Inc. Methods and compositions for controlling protein assembly or aggregation
US6127393A (en) 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
US6441009B1 (en) 1998-08-01 2002-08-27 Novactyl, Inc. Agent and method of preventing and treating heavy metal exposure and toxicity
US6403618B1 (en) 2000-02-15 2002-06-11 Novactyl, Inc. Agent and method for controlling angiogenesis
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
EP2149372B1 (en) * 2008-07-31 2014-04-02 Universität Ulm Use of opioids of the methadone group for the treatment of resistant cancer patients
CN104016937B (zh) * 2014-05-09 2016-12-07 中科院广州化学有限公司 一种n-芳基氧氮杂卓酮类化合物及其制备方法
WO2019173761A1 (en) 2018-03-09 2019-09-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546214A (en) * 1967-07-11 1970-12-08 Boehringer Sohn Ingelheim Amino-substituted dibenz(b,f)(1,4)oxazepin-11(10h)-ones

Also Published As

Publication number Publication date
AU2074292A (en) 1993-03-04
CA2075861C (en) 2003-08-05
PL168707B1 (pl) 1996-03-29
JP3136427B2 (ja) 2001-02-19
FI923285A0 (fi) 1992-07-17
EP0529386A1 (en) 1993-03-03
PL295633A1 (en) 1993-03-08
CN1038749C (zh) 1998-06-17
NO972247D0 (no) 1997-05-16
IL102542A (en) 1995-12-31
NO309603B1 (no) 2001-02-26
NO923049D0 (no) 1992-08-03
NO301586B1 (no) 1997-11-17
ZA925287B (en) 1993-04-28
DE69217594D1 (de) 1997-04-03
ES2097841T3 (es) 1997-04-16
TW213905B (no) 1993-10-01
HU9202319D0 (en) 1992-10-28
AU642602B2 (en) 1993-10-21
CA2075861A1 (en) 1993-02-27
MX9204791A (es) 1993-01-01
GR3022698T3 (en) 1997-05-31
DK0529386T3 (da) 1997-07-28
HK1005029A1 (en) 1998-12-18
US5173486A (en) 1992-12-22
ATE149158T1 (de) 1997-03-15
KR100204119B1 (ko) 1999-06-15
KR930004281A (ko) 1993-03-22
RU2086545C1 (ru) 1997-08-10
HU214584B (hu) 1998-04-28
NO972247L (no) 1997-05-16
FI923285A (fi) 1993-02-27
IL102542A0 (en) 1993-01-14
DE69217594T2 (de) 1997-10-02
JPH05194442A (ja) 1993-08-03
CN1069731A (zh) 1993-03-10
FI112656B (fi) 2003-12-31
EP0529386B1 (en) 1997-02-26
HUT63837A (en) 1993-10-28

Similar Documents

Publication Publication Date Title
NO923049D0 (no) Substituerte dibenz(b,f)(1,4)oksazepin-11(10h)-oner, fremgangsmaate til fremstilling derav og preparater inneholdende slike
MY129970A (en) Hypolipidaemic compounds
NO923679D0 (no) Nye substituerte taksaner og farmasoeytiske preparater sominneholder slike
HUT66660A (en) Intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
DE3681109D1 (de) Stickstoffhaltige heterozyklische verbindungen.
DE69524154T2 (de) 7-O-Ether von Taxanderivaten
DK0382660T3 (da) Dioxaphosphorinanforbindelser og dermed stabiliserede polyolefinmaterialer
ATE88190T1 (de) Zyklisches antikoagulierendes peptid.
SE9001269D0 (sv) 2-substituted n,n-ditrimethoxybenzoyl piperazines,a preparation process of the same and therapeutic compositions containing them
DK659089D0 (da) Mevalonolactoner af pyrazolopyridintypen
DE69600714D1 (de) Antiallergische Zusammensetzung enthaltend eine Phosphorsäurediester-Verbindung
DE69208384D1 (de) Fungizide Furanonderivate
BR9405997A (pt) Composições antitumorais e métodos de tratamento
ATE81128T1 (de) Substituierte chinoxaline.
DK509186D0 (da) 1,4-dihydropyridinderivater og laegemiddel indeholdende saadanne derivater
ES2055476T3 (es) Compuestos del tiocarbamoilacetonitrilo.
NO923992L (no) Farmasoeytiske blandinger inneholdende triazolderivater for rektal administrering